Chemotherapy induced neuropathy treated with PEA: Montalcini explains

Schermafbeelding 2013-01-31 om 14.49.19

Schermafbeelding 2013-01-31 om 14.49.22

Schermafbeelding 2013-01-31 om 14.49.25

Schermafbeelding 2013-01-31 om 14.49.27

PEA and Kahler: palmitoylethanolamide protects

Schermafbeelding 2013-01-31 om 14.49.33

Palmitoylethanolamide (Normast, PeaPure) against chemotherapy

Copyright.svgCopyright on all cartoons by the Chronic Pain Coalition, JMKHLOGO

Source:

CNS Neurol Disord Drug Targets. 2011 Dec;10(8):916-20.
Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy.
Truini A, Biasiotta A, Di Stefano G, La Cesa S, Leone C, Cartoni C, Federico V, Petrucci MT, Cruccu G.

Conclusion authors:

All together, the results reported here indicate that PEA may represent an innovative therapeutic tool for patients undergoing chemotherapy-induced painful neuropathy to obtain pain relief as well as to restore myelinated-fibre function without increasing the toxic effects that they were already enduring. Although a proper randomised controlled study (possibly using a drug with established efficacy in relieving pain as a control) is necessary to confirm the efficacy of PEA therapy, the present study provides evidence concerning the ability of an endogenous fatty acid amide to improve neurophysiologic parameters in humans.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: